In addition, while this study has provided valuable insights into the potential benefits of EcN-GLP-1 in the context of diabetes management, several limitations warrant consideration: 1 The primary focus of this study centered on discerning the effects of EcN-GLP-1 over a 9-week period. This evidence concerns the gene GCG and diabetes mellitus.